Journal
Scientific Reports
Publication Date
2021
Volume
11
Issue
1
First Page
14486
Document Type
Open Access Publication
DOI
10.1038/s41598-021-93601-1
Rights and Permissions
Babcock, M.C., Mikulka, C.R., Wang, B. et al. Substrate reduction therapy for Krabbe disease and metachromatic leukodystrophy using a novel ceramide galactosyltransferase inhibitor. Sci Rep 11, 14486 (2021). https://doi.org/10.1038/s41598-021-93601-1 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
Recommended Citation
Babcock, Michael C.; Mikulka, Christina R.; Nelvagal, Hemanth R.; Jiang, Xuntian; Sands, Mark S.; and al, et, "Substrate reduction therapy for Krabbe disease and metachromatic leukodystrophy using a novel ceramide galactosyltransferase inhibitor." Scientific Reports. 11, 1. 14486 (2021).
https://digitalcommons.wustl.edu/open_access_pubs/10598
